Navigation Links
Healionics Awarded $900k Grant from NIH
Date:9/20/2012

SEATTLE, Sept. 20, 2012 /PRNewswire/ -- Healionics Corporation received a $909,165 Phase II Small Business Innovation Research (SBIR) grant award from the National Institute of General Medical Sciences division of the National Institutes of Health (NIH) for preclinical studies to advance STARcuffTM, a STAR® Biomaterial-based anti-infective exit site sleeve for hemodialysis catheters. Andrew Marshall, Healionics' Chief Technology Officer, is the Principal Investigator for this research project.

(Logo: http://photos.prnewswire.com/prnh/20120920/SF77922LOGO)

Titled, "Anti-Infective Dermal Integration Sleeves for Needle-Free Dialysis Access Devices," the award provides funding to refine the STARcuff anti-infection technology and broaden its range of device applicability.

Hemodialysis patients are at high risk for life-threatening bloodstream infections. Treatment of catheter-associated infections at $35,000 to $60,000 per episode exceeds the yearly cost of routine dialysis sessions. Nearly half of these infections proceed extraluminally via the exit site.

"Catheters loaded with active antimicrobial agents or antiseptics are a controversial option for chronic dialysis patients due to the serious threat of microbial resistance," says Marshall. "STARcuff is an attractive approach because it can potentially provide long-term protection against infection without any active agents."

More information about SBIR grants from the National Institutes of Health can be found at http://grants.nih.gov/grants/funding/sbir.htm.

About Healionics Corporation
Healionics develops and manufactures STAR® Biomaterials for implanted medical devices. The precisely controlled pore structure of the innovative STAR technology induces a favorable integrated healing response, overcoming fibrotic reactions and infection issues to enhance medical device performance and longevity.  The company has two medical device subsidiaries: iSTAR Medical and qSTAR Medical.

Websites:
     www.healionics.com 
     www.istarmed.com 
     www.qstarmed.com


'/>"/>
SOURCE Healionics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Eutropics Pharmaceuticals awarded NCI contract to develop companion diagnostic for guiding AML treatments
2. Managed Health Care Associates, Inc. (MHA) Awarded Commonwealth of Massachusetts GPO Contract
3. Sequent Medical, Inc. Awarded U.S. Patent for MicroBraid Technology
4. Avaxia Biologics is Awarded U.S. Patent for Antibody Therapy for Modulating Function of Intestinal Receptors and Methods of Treating Diabetes and Obesity
5. ChanTest Awarded $1 Million Grant for Predictive Assays using Stem Cell-Derived Human Cardiomyocytes
6. Elusys Awarded Additional $14.5 Million Under Existing U.S. Government Contracts Supporting Expanded Human Safety Studies of ETI-204 for Treatment of Inhalational Anthrax
7. Antigen Discovery Inc. Awarded Phase I SBIR Grant to Develop a Fully Integrated Microfluidic Point of Care Diagnostic Device
8. Antigen Discovery, Inc. Awarded Phase II SBIR Grant to Identify Biomarkers Associated with Protection against Malaria
9. Luminex Corporation Awarded $11 Million Contract by Defense Threat Reduction Agency (DTRA)
10. Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
11. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... , May 23, 2016 ... titled, " Exocrine Pancreatic Insufficiency Market - Global Industry ... 2023 ." According to the report, the exocrine pancreatic ... of 8.3% from 2015 to 2023 to reach US$2.85 ... is a condition characterized by the deficiency of the ...
(Date:5/23/2016)... -- The World Health Organization (WHO) expanded the Intended Use ... aged 13 years, and above. Effective immediately, the PrePex device, ... adolescent males in the 14 priority countries in Southern and ... male circumcision device to receive WHO Prequalification on 31 May ... said: " The expanded use of PrePex for ...
(Date:5/23/2016)... 23, 2016 Gamida Cell, a ... of cancer and orphan genetic diseases, announced today it ... million from the Israel Innovation Authority (formerly the Office ... Economy and Industry. The mission of the Israel Innovation ... industries, including science and technology, while stimulating economic growth. ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... ... New Brunswick, New Jersey: This year marks Children’s Specialized Hospital ’s 125th ... the anniversary, the hospital has themed the milestone “Hats Off” and kicked off the ... on Saturday, May 21, at Johnson Park in Piscataway, New Jersey. , ...
(Date:5/24/2016)... — , ... (PRWEB) ... of three new members of its Advisory Board. Joining the ... Sarah Kusch. “All three of them embody the mission of our ... are very fortunate to have them as we continue to expand ...
(Date:5/24/2016)... ... ... Boyd Industries, a leading supplier of dental chairs and cabinetry , will ... dentistry , at AAPD 2016, the annual conference and trade show of the American ... keeps dental hand pieces and other anxiety-provoking pieces of the dental delivery system out ...
(Date:5/24/2016)... Angeles, CA (PRWEB) , ... May 24, 2016 ... ... to everything egg freezing, today announced the official relaunch of its community and ... use their frozen eggs. Eggsurance's mission is to create a safe and welcoming ...
(Date:5/24/2016)... Maryland (PRWEB) , ... May 24, 2016 , ... ... announced the appointment of Jonathan (Jon) Otterstatter to its board of ... is a proven leader in the development of technological innovations that lead to ...
Breaking Medicine News(10 mins):